Citi Pharma Limited (PSX:CPHL)
Pakistan · Delayed Price · Currency is PKR 61.79
-1.28 (-2.03%)
At close: Nov 6, 2026
Citi Pharma Balance Sheet
Financials in millions PKR. Fiscal year is July - June.
Millions PKR. Fiscal year is Jul - Jun.
Assets
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Cash & Equivalents | 270.81 | 208.82 | 603.55 | 87.9 | 54.61 | 27.48 |
Short-Term Investments | 3.27 | 136.04 | 919.59 | 1,222 | 1,393 | 1,660 |
Trading Asset Securities | - | 3.38 | 66.5 | 108.81 | 132.36 | 312.12 |
Cash & Short-Term Investments | 274.08 | 348.24 | 1,590 | 1,418 | 1,580 | 2,000 |
Cash Growth | -70.06% | -78.09% | 12.08% | -10.26% | -20.97% | -34.96% |
Accounts Receivable | 3,930 | 3,470 | 3,078 | 2,197 | 1,882 | 1,402 |
Other Receivables | - | 183.81 | 150.02 | 203.26 | 96.29 | 45.77 |
Receivables | 3,930 | 3,654 | 3,228 | 2,400 | 1,978 | 1,447 |
Inventory | 3,274 | 3,714 | 3,930 | 3,203 | 2,609 | 1,692 |
Other Current Assets | 874.78 | 1,009 | 723.98 | 613.03 | 415.98 | 458.15 |
Total Current Assets | 8,353 | 8,725 | 9,472 | 7,635 | 6,584 | 5,597 |
Property, Plant & Equipment | 9,332 | 9,255 | 8,688 | 3,530 | 3,122 | 2,258 |
Long-Term Accounts Receivable | - | - | - | - | 23.65 | - |
Other Long-Term Assets | 279.98 | 279.98 | 279.98 | 274.76 | 254.54 | 272.06 |
Total Assets | 17,965 | 18,260 | 18,439 | 11,439 | 9,984 | 8,127 |
Liabilities
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Accounts Payable | 3,242 | 3,479 | 3,234 | 3,374 | 1,938 | 1,618 |
Accrued Expenses | 94.42 | 32.79 | 280.74 | 216.54 | 206.62 | 149.67 |
Short-Term Debt | 2,856 | 2,870 | 2,869 | 1,437 | 1,768 | 521.57 |
Current Portion of Long-Term Debt | 91.66 | 56.42 | - | 12.86 | 55.88 | 160.69 |
Current Portion of Leases | - | 28.39 | 15.8 | 5.42 | 5.67 | 4.77 |
Current Income Taxes Payable | 136.51 | 484.41 | 519.68 | 470.83 | 393.19 | 404.18 |
Current Unearned Revenue | - | - | 56.1 | 0.58 | 3.04 | 14.51 |
Other Current Liabilities | 3.44 | 3.44 | 330.23 | 83.03 | 82.1 | 137.28 |
Total Current Liabilities | 6,424 | 6,954 | 7,305 | 5,599 | 4,453 | 3,010 |
Long-Term Debt | 36.73 | 57.24 | - | - | 8.54 | 250.17 |
Long-Term Leases | 83.09 | 87.87 | 64.86 | - | 4.37 | 6.27 |
Long-Term Unearned Revenue | - | - | - | - | 0.58 | 32.17 |
Pension & Post-Retirement Benefits | - | - | 99.7 | 82.62 | 50.34 | 31.94 |
Long-Term Deferred Tax Liabilities | - | - | 102.07 | 124.09 | 94.24 | 82.3 |
Other Long-Term Liabilities | 338.54 | 326.83 | - | - | - | - |
Total Liabilities | 6,882 | 7,426 | 7,572 | 5,806 | 4,611 | 3,413 |
Shareholders' Equity
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Common Stock | 2,285 | 2,285 | 2,285 | 2,285 | 2,285 | 2,285 |
Additional Paid-In Capital | 1,392 | 1,392 | 1,392 | 1,392 | 1,392 | 1,392 |
Retained Earnings | 2,022 | 1,773 | 1,807 | 1,648 | 1,388 | 728.54 |
Comprehensive Income & Other | 5,385 | 5,385 | 5,385 | 309.29 | 309.29 | 309.29 |
Shareholders' Equity | 11,083 | 10,834 | 10,868 | 5,633 | 5,373 | 4,714 |
Total Liabilities & Equity | 17,965 | 18,260 | 18,439 | 11,439 | 9,984 | 8,127 |
Additional Metrics
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Jun '26 Jun 30, 2026 | Jun '25 Jun 30, 2025 | Jun '24 Jun 30, 2024 | Jun '23 Jun 30, 2023 | Jun '22 Jun 30, 2022 |
Total Debt | 3,068 | 3,100 | 2,950 | 1,455 | 1,843 | 943.48 |
Net Cash (Debt) | -2,793 | -2,751 | -1,360 | -36.55 | -262.2 | 1,056 |
Net Cash Growth | - | - | - | - | - | -61.65% |
Net Cash Per Share | -12.24 | -12.04 | -5.95 | -0.16 | -1.15 | 4.66 |
Filing Date Shares Outstanding | 228.25 | 228.46 | 228.46 | 228.46 | 228.46 | 228.46 |
Total Common Shares Outstanding | 228.25 | 228.46 | 228.46 | 228.46 | 228.46 | 228.46 |
Working Capital | 1,929 | 1,770 | 2,166 | 2,035 | 2,131 | 2,586 |
Book Value Per Share | 48.56 | 47.42 | 47.57 | 24.66 | 23.52 | 20.63 |
Tangible Book Value | 11,083 | 10,834 | 10,868 | 5,633 | 5,373 | 4,714 |
Tangible Book Value Per Share | 48.56 | 47.42 | 47.57 | 24.66 | 23.52 | 20.63 |
Land | - | 6,940 | 6,940 | 1,865 | 1,865 | 1,421 |
Buildings | - | 776.96 | 673.95 | 661.56 | 485.03 | 309.33 |
Machinery | - | 2,343 | 1,758 | 1,525 | 1,194 | 915.01 |
Construction In Progress | - | 67.89 | 49.11 | 130.04 | 70.39 | 14.33 |